Ori Gutwerg Ani Pharmaceuticals Inc (ANIP) insider trading activity

Ori Gutwerg is SVP, GENERICS of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 90,778 shares of ANIP, which is worth approximately $6.02 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 3,314 shares (Common Stock) at a price of $60.62 per share, resulting in proceeds of $200,894. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.8K

17.55% 3M change

13.17% 12M change

Total Value Held $6.02 Million

Ori Gutwerg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2025	SELL Payment of exercise price or tax liability	$200,894 $60.62 p/Share	3,314 Reduced 3.52%	90,778 Common Stock
Mar 05 2025	SELL Open market or private sale	$323,093 $60.01 p/Share	5,384 Reduced 5.41%	94,092 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	$9,447 $31.49 p/Share	300 Added 0.3%	99,476 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$97,167 $61.89 p/Share	1,570 Reduced 1.56%	99,176 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$68,759 $58.92 p/Share	1,167 Reduced 1.15%	100,746 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$84,019 $58.92 p/Share	1,426 Reduced 1.38%	101,913 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	26,112 Added 20.17%	103,339 Common Stock
Jun 05 2024	SELL Open market or private sale	$199,995 $67.0 p/Share	2,985 Reduced 3.72%	77,227 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$166,374 $66.71 p/Share	2,494 Reduced 3.02%	80,212 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$106,241 $67.67 p/Share	1,570 Reduced 1.86%	82,706 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$71,592 $57.55 p/Share	1,244 Reduced 1.45%	84,276 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	24,605 Added 22.34%	85,520 Common Stock
Aug 23 2023	SELL Open market or private sale	$970,850 $62.39 p/Share	15,561 Reduced 20.35%	60,915 Common Stock
Aug 23 2023	BUY Exercise of conversion of derivative security	$425,177 $31.49 p/Share	13,502 Added 15.01%	76,476 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$103,586 $44.23 p/Share	2,342 Reduced 6.44%	34,027 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	28,947 Added 31.49%	62,974 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$57,426 $45.04 p/Share	1,275 Reduced 3.39%	36,369 Common Stock
Apr 27 2022	BUY Grant, award, or other acquisition	-	6,476 Added 14.68%	37,644 Common Stock
Mar 24 2022	BUY Grant, award, or other acquisition	-	19,428 Added 38.4%	31,168 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$46,972 $40.25 p/Share	1,167 Reduced 9.04%	11,740 Common Stock
Feb 15 2021	BUY Grant, award, or other acquisition	-	12,907 Added 50.0%	12,907 Common Stock

Ori Gutwerg

SVP, GENERICS

Baudette, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Value

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP

Account